| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |